A new study using a pedometer as part of a structured education program reduced the chances of Type 2 diabetes by more than 50% in those at risk of developing the condition, reveals a new study. By using a device that costs less than $20 you can prevent a disease that …

Cigarette smoking is a well-known risk factor for Type 2 diabetes, but new research from Johns Hopkins suggests that quitting the habit may actually raise diabetes risk in the short term.

Traditional diagnostic criteria for metabolic syndrome are not reliable in children, researchers from the National Institutes of Health report.

With new financing, the All-in-One blood glucose monitor will be submitted to the FDA for approval probably within six months.

India-based drug maker Dr. Reddy’s Labs announced the success of a new diabetic compound from the first phase III study. According to the study, their investigational agent, Balaglitazone, a diabetes compound, was successful in the trial, meeting the study’s primary endpoint of reduction in HbA1c.

News from a trial of darbepoetin alfa in Type 2 diabetes and chronic kidney disease.

Researchers found that older people with memory loss are three times more likely to develop dementia if they also have diabetes.

Consumption and plasma levels of three micronutrients had no clear association with diabetic retinopathy, according to a meta-analysis involving 4,100 patients.

A research team led by a Michigan State University professor has discovered a link between diabetes and bone marrow nerve damage that may help treat one of the disease’s most common and potentially blindness-causing complications.

Contrary to the widely-held belief, there is no proof that non-insulin-dependent patients with Type 2 diabetes benefit from glucose self-monitoring. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG).